Philips and Brainlab Collaborate on Intra-Operative MRI Solutions

Royal Philips ElectronicsRoyal Philips Electronics (AEX: PHI, NYSE: PHG) is collaborating with Brainlab AG, a manufacturer of software-driven medical technology that supports targeted, less-invasive treatment, to create a comprehensive intra-operative solution with the goal of streamlining neurosurgery procedures. Ingenia MR-OR* is based on Philips digital broadband Ingenia magnetic resonance imaging (MRI)system, 1.5T and 3.0T, is designed to be combined with Brainlab's integrated OR solutions.

Magnetic resonance imaging (MRI) is used pre-operatively in neurosurgery planning for the removal of tumors in the brain. Traditionally during this surgery updated MR patient information is not available to surgeons, neither allowing them to see the immediate impact of the intervention nor offering guidance to adapt surgical navigation in real-time.

The Philips' MR-OR solution is designed to allow neurosurgeons to visualize the results of neurological procedures in real-time. This permits immediate access of patient information to facilitate surgical decision making. In addition, the solution allows for the removal of residual amount of a tumor before the surgical procedure is finished.

"Our collaboration with Brainlab offers a strong intra-operative solution for neurosurgeons", Falko Busse, vice president, MR therapy, for Philips Healthcare said. "With the unique capabilities that both of our solutions provide, including the possibility to connect two ORs on the front and back of the Ingenia MRI system, we are addressing neurosurgical needs."

The Ingenia MR-OR is based on a two-room solution, making it possible for the system to be used both for intra-operative as well as for standard diagnostic imaging. Its design enables a short and smooth transfer of the patient to the system and fast imaging, thereby providing a quick review of the neurosurgery procedure. In addition, the Ingenia MR-OR can be used with two operating rooms, one on each side of the MRI magnet. This provides more flexibility for neurosurgery centers, offering the possibility to schedule patients from multiple ORs on the same MRI.

"Brainlab's Integrated OR helps to ensure that surgeons have access to high navigation accuracy throughout neurosurgery procedures", said Stephan Holl, COO, Brainlab AG. "The technology automatically re-registers the newly generated images taken with Ingenia MR-OR, facilitating the ability to immediately continue the surgery with re-registered surgical navigation information after the scan has been performed. Furthermore, all relevant patient information from intra- or extra-operative sources can be displayed and managed on Brainlab's patient data management system."

Related news articles:

* Availability of Ingenia MR-OR is expected end 2012

About Royal Philips Electronics
Royal Philips Electronics of the Netherlands (NYSE: PHG, AEX: PHI) is a diversified health and well-being company, focused on improving people's lives through timely innovations. As a world leader in healthcare, lifestyle and lighting, Philips integrates technologies and design into people-centric solutions, based on fundamental customer insights and the brand promise of "sense and simplicity." Headquartered in the Netherlands, Philips employs approximately 122,000 employees with sales and services in more than 100 countries worldwide. With sales of EUR 22.6 billion in 2011, the company is a market leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as lifestyle products for personal well-being and pleasure with strong leadership positions in male shaving and grooming, portable entertainment and oral healthcare.

Most Popular Now

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...

ChatGPT fails at heart risk assessment

Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest...

Study Shows ChatGPT Failed when Challeng…

With artificial intelligence (AI) poised to become a fundamental part of clinical research and decision making, many still question the accuracy of ChatGPT, a sophisticated AI language model, to support...

Virtual Reality Shows Promise in Fightin…

A new study published in JMIR Mental Health sheds light on the promising role of virtual reality (VR) in treating major depressive disorder (MDD). Titled "Examining the Efficacy of Extended...

AXREM and Highland Marketing Partner to …

AXREM represents member companies that collectively provide UK hospitals with most of their diagnostic medical imaging technology, and radiotherapy equipment. The association has seen substantial growth in recent years, with membership...